drugset / Trial / NCT06843122
Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)
Phase 2
Not yet recruiting
105 enrolled
Medical University of Warsaw
Medical Research Agency, Poland · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The goal of this study is to investigate the safety and efficacy of allogenic mesenchymal stem cells isolated from adipose tissue as the treatment for chronic wounds in diabetic foot syndrome in a double-blinded three armed setup.
Timeline
- Start
- 2025-03-08
- Primary completion
- 2027-02-28
- Completion
- 2027-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADSC | Cell therapy | — | — |